Affomix to generate antibodies against proprietary targets chosen by Kalgene Affomix Corporation.

Affomix to generate antibodies against proprietary targets chosen by Kalgene Affomix Corporation, a pioneer in the development of automated, high-throughput monoclonal antibody selection technology, announced today that Kalgene Pharmaceuticals Inc. Kalgene Pharmaceuticals Inc. Financial terms of the ongoing support agreementContinue reading… Affomix to generate antibodies against proprietary targets chosen by Kalgene Affomix Corporation.